Medical research

A new target for the treatment of idiopathic pulmonary fibrosis

An article published in Experimental Biology and Medicine identifies a new target for the treatment of idiopathic pulmonary fibrosis. The study, led by Dr. Huaping Dai in the Department of Pulmonary and Critical Care Medicine ...

Oncology & Cancer

Mutations synergize in pediatric brain cancer

A new Northwestern Medicine study finds that a combination of two mutations cause a form of pediatric brain tumors to become more deadly, according to findings published in Nature Communications.

Neuroscience

Experimental drug shows promise for genetic form of ALS

An early stage trial of an investigational therapy for amyotrophic lateral sclerosis (ALS) suggests that people could tolerate the experimental drug and, in exploratory results, the experimental drug was linked to possible ...

Medications

New drug mimics benefits of ketamine for depression

A new small-molecule drug produced a rapid antidepressant response similar to that of ketamine when tested in mice, a new Yale-led study published April 16 in the Journal of Clinical Investigation shows.

Medical research

Experimental drug delivers one-two punch to vision loss

In studies with lab-grown human cells and in mice, Johns Hopkins Medicine researchers have found that an experimental drug may be twice as good at fighting vision loss as previously thought.

Medications

Experimental drug shows promise for opioid withdrawal symptoms

While medicines are available to relieve withdrawal symptoms in people recovering from opioid addiction, they cause side effects and can maintain the brain changes that led to addiction in the first place, which can lead ...

Oncology & Cancer

New hope for treating childhood brain cancer

There could be new treatments on the horizon for diffuse intrinsic pontine glioma, or DIPG, a devastating form of brain cancer that afflicts young children and is currently incurable. Recent experiments in animal models of ...

page 1 from 23

Experimental drug

An experimental drug is a substance that has been tested in a laboratory and has got approval from regulatory authorities to be tested in people. In the United States, the body responsible for approval is the U.S. Food and Drug Administration (FDA). A drug may be approved for use in one disease or condition but be considered experimental or investigational in other diseases or conditions.

This text uses material from Wikipedia, licensed under CC BY-SA